AusPAR: Tocilizumab (rch)
Australian Public Assessment Report
Device/Product Name
Actemra
Active ingredients
Tocilizumab (rch)
AusPAR Date
Published
Sponsor
Submission Number
PM-2018-05341-1-3
Submission Type
Extension of indications
Decision
Approved